Press Releases

News & Events

Icagen enters into Collaboration to Develop and Commercialize Therapy for Neurological Diseases. Collaboration includes the initial program utilizing Icagen’s Drug Discovery Platform.

Icagen Receives Award from the Cystic Fibrosis Foundation to Discover Transformative Therapies to Treat Cystic Fibrosis

Icagen and Omdana Therapeutics Announce Collaboration to Pursue Therapies for Patients with Pulmonary Hypertension

Icagen to Showcase its Integrated Drug Discovery Platform at BIO International

Icagen Announces Collaboration With Bayer To Develop Novel XRpro® Assays

Icagen announces distribution agreement with On Target for advancing early drug discovery in Japanese market

Icagen Appoints Chris Mathes as Chief Commercial Officer

Icagen Acquires Nanion's SyncroPatch384 High-Throughput Electrophysiology Platform

Icagen Acquisition of Sanofi Arizona Research Facility Complete

Icagen Acquires Sanofi's Oro Valley, Arizona Research Facility

1 2 3
Next »
© 2017 Icagen, Inc. All Rights Reserved.
Privacy Policy Disclaimer Site Map
LinkedIn Twitter